SUMMARY
This meeting provided confirmation of the impressive results and the safety of CART, for several histological entities of lymphoma provided by real-life cases.
(BELG J HEMATOL 2023;14(5):211–2)
By: M. Maerevoet MD
This meeting provided confirmation of the impressive results and the safety of CART, for several histological entities of lymphoma provided by real-life cases.
(BELG J HEMATOL 2023;14(5):211–2)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
